-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Janux Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q2 2024.
- Janux Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 54.5M shares, a 30.2% increase year-over-year.
- Janux Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 44M shares, a 6.14% increase from 2022.
- Janux Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 41.5M shares, a 76.2% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)